City of Hope

DxTerity aims to develop a genomic blood test to identify which cancer patients are most likely to benefit from radiation therapy or are at risk for toxicity.

This Week in PNAS

In PNAS this week: analytical method for assessing shared variants, treatment targets in hereditary pancreatic cancer, and more.

In individuals diagnosed with prostate cancer before the age of 45, researchers saw enhanced expression of immune- and inflammation-related genes.

As part of the deal, TGen will also become a subsidiary of City of Hope's parent organization, but will remain a non-profit headquartered in Arizona.

Researchers will study how prior hypoglycemic episodes can result in the "metabolic memory" of persistent vascular complications.

CHICAGO (GenomeWeb News) – Researchers are tracking down genetic variants that they hope will help identify childhood cancer patients at increased risk of treatment-related health complications later in life, City of Hope researcher Smita Bhatia reported at the annual American Society of Clinical

NEW YORK (GenomeWeb) – Sangamo BioSciences today said that the California Institute for Regenerative Medicine has awarded $5.6 million grant to researchers at City of Hope to develop an HIV/AIDS therapeutic based on Sangamo's zinc finger nuclease genome editing technology.

The Biological Research Center of the Hungarian Academy of Sciences and Glaxo Group Limited, a subsidiary of GlaxoSmithKline, have been jointly awarded US Patent No. 8,389,802, "Artificial chromosomes, uses thereof, and methods for preparing artificial chromosomes.

City of Hope has been awarded US Patent No. 8,227,191, "Method for amplification and detection of RNA sequences."
George Murakawa, Bruce Wallace, John Zaia, and John Rossi are named as inventors on the patent.

Lawrence Livermore National Security has been awarded RE43,365, "Apparatus for chemical amplification based on fluid partitioning in an immiscible liquid." The patent is a reissuance of RE41,780 issued in September 2010, which itself was a reissuance of US Patent No.

Pages

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.